GO:0004800 thyroxine 5'-deiodinase activity: Mechanism, Genes and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0004800 thyroxine 5'-deiodinase activity catalyzes the conversion of L-thyroxine (T4) to the active thyroid hormone 3,3',5-triiodo-L-thyronine (T3) by removing an outer-ring iodine.
• This enzymatic activity is mediated by selenoproteins, specifically the type I, II, and III iodothyronine deiodinases (DIO1, DIO2, DIO3), which contain the rare amino acid selenocysteine in their active site.
• The reaction requires reducing equivalents such as dithiothreitol or glutathione and produces iodide and an oxidized acceptor.
• Tissue-specific expression of thyroxine 5'-deiodinase activity is critical for local control of thyroid hormone action in the brain, pituitary, brown adipose tissue, liver, and pineal gland.
• Altered thyroxine 5'-deiodinase activity has been implicated in human brain tumors and postpartum thyroiditis, highlighting its clinical relevance.
• Researchers study this activity using biochemical assays, cell models, and CRISPR-based gene editing to dissect its role in development, metabolism, and disease.
Description
Thyroxine 5'-deiodinase activity (GO:0004800) is a molecular function that catalyzes the outer-ring deiodination of L-thyroxine (T4) to yield the biologically active thyroid hormone 3,3',5-triiodo-L-thyronine (T3). This reaction is essential for thyroid hormone signaling, as T3 binds to nuclear thyroid hormone receptors with much higher affinity than T4, thereby regulating gene expression, development, and metabolic rate. The enzyme belongs to the family of selenoproteins, which incorporate selenocysteine, a rare amino acid critical for catalytic efficiency. The activity is widely distributed across tissues, including the anterior pituitary, brown adipose tissue, liver, pineal gland, and frontal cortex, where it modulates local thyroid hormone availability. In the pineal gland, thyroxine 5'-deiodinase activity exhibits a nighttime increase and is influenced by light exposure and sympathetic innervation, linking it to circadian rhythms. Ontogenetic studies in rats have shown that pineal thyroxine 5'-deiodinase activity develops in parallel with plasma melatonin concentrations, suggesting a role in neuroendocrine maturation. Given its central role in thyroid hormone homeostasis, thyroxine 5'-deiodinase activity is a subject of intense research in endocrinology, neuroscience, and oncology. For example, human brain tumors exhibit altered thyroxine 5-deiodinase activity, and postpartum thyroiditis is associated with changes in thyroid hormone metabolism. Understanding the regulation and function of this enzyme is therefore crucial for developing therapeutic strategies for thyroid-related disorders and beyond.
thyroxine 5'-deiodinase activity At A Glance
| GO ID | GO:0004800 |
|---|---|
| GO term | thyroxine 5'-deiodinase activity |
| Ontology | molecular_function |
| Synonym | type I iodothyronine deiodinase activity; type II iodothyronine deiodinase activity; iodothyronine outer ring monodeiodinase activity; thyroxine deiodinase activity |
| Major function | Conversion of L-thyroxine (T4) to active 3,3',5-triiodo-L-thyronine (T3) via outer-ring deiodination |
| Cofactors | Reducing equivalents (e.g., dithiothreitol, glutathione), selenocysteine in active site |
| Subcellular localization | Endoplasmic reticulum membrane; plasma membrane |
| Tissue distribution | Pituitary, brown adipose tissue, liver, pineal gland, frontal cortex, brain |
What Is GO:0004800?
Thyroxine 5'-deiodinase activity (GO:0004800) is defined as the catalysis of the reaction: 3,3',5-triiodo-L-thyronine + iodide + acceptor + H+ = L-thyroxine + acceptor-H2. In simpler terms, it is the enzymatic removal of an iodine atom from the outer ring of thyroxine (T4) to produce the active hormone T3, using a reducing acceptor molecule.
Why Is thyroxine 5'-deiodinase activity Important in Cell Biology?
Thyroxine 5'-deiodinase activity is essential for thyroid hormone action because it generates the active hormone T3, which regulates gene expression, energy metabolism, and development. Dysregulation of this activity has been linked to metabolic disorders, neurological conditions, and cancer, making it a key target for research and therapeutic intervention.
• Controls local and systemic levels of active thyroid hormone T3, influencing metabolism, growth, and development.
• Expressed in diverse tissues such as pituitary, brown adipose tissue, liver, and brain, where it modulates tissue-specific thyroid hormone action.
• Exhibits circadian regulation in the pineal gland, linking thyroid hormone metabolism to biological rhythms.
• Plays a role in neuroendocrine development, as shown by ontogenetic studies in rats.
• Altered activity is observed in human brain tumors, suggesting a role in tumor biology.
• Associated with postpartum thyroiditis, an autoimmune thyroid disorder.
• Selenoprotein nature makes it sensitive to selenium status, with implications for nutrition and health.
• Provides a model for studying enzyme kinetics and redox regulation in hormone metabolism.
• Potential target for drugs modulating thyroid hormone signaling in metabolic diseases.
• CRISPR-based editing of DIO genes enables precise functional studies in cell and animal models.
What Happens During thyroxine 5'-deiodinase activity?
Substrate Binding and Recognition
In simple terms: The enzyme grabs the thyroid hormone T4 and positions it for chemical modification.
Thyroxine 5'-deiodinase binds L-thyroxine (T4) in its active site, which contains a selenocysteine residue essential for catalysis. The enzyme specifically recognizes the outer ring of T4, distinguishing it from inner-ring deiodination that inactivates the hormone. Substrate binding is influenced by the redox state of the cell and the availability of reducing cofactors.
Catalytic Deiodination
In simple terms: The enzyme removes an iodine atom from T4, turning it into the active hormone T3.
The catalytic mechanism involves the reductive elimination of an iodine atom from the outer ring of T4, producing 3,3',5-triiodo-L-thyronine (T3) and iodide. This reaction requires a reducing acceptor, such as dithiothreitol or glutathione, which donates electrons to regenerate the selenocysteine residue. The reaction is stereospecific and yields T3 as the major product.
Product Release and Recycling
In simple terms: The newly made T3 is released, and the enzyme is ready to act again.
After catalysis, T3 is released from the active site and can bind to thyroid hormone receptors in the nucleus or cytoplasm. The oxidized acceptor is reduced by cellular reducing systems, allowing the enzyme to cycle through multiple rounds of catalysis. The iodide produced is either recycled or excreted.
Tissue-Specific Regulation
In simple terms: Different tissues control this enzyme's activity to meet their local needs for active thyroid hormone.
Thyroxine 5'-deiodinase activity is regulated in a tissue-specific manner. In the anterior pituitary, it is localized to specific subcellular fractions and modulates feedback on TSH secretion. In brown adipose tissue, the activity is high and contributes to thermogenesis. Human liver expresses the activity, where it affects systemic T3 levels. In the pineal gland and frontal cortex, the activity shows nighttime increases and is influenced by light and sympathetic innervation. Ontogenetic studies reveal that pineal activity develops postnatally in rats.
Key Genes Involved in GO:0004800 thyroxine 5'-deiodinase activity
The following genes encode proteins that either possess thyroxine 5'-deiodinase activity or are directly involved in its regulation and function.
| Gene | Major Role | Research Relevance |
|---|---|---|
| DIO1 | Type I iodothyronine deiodinase; catalyzes outer-ring deiodination of T4 to T3 | Major contributor to plasma T3; target for metabolic studies |
| DIO2 | Type II iodothyronine deiodinase; provides local T3 in brain, pituitary, brown adipose tissue | Critical for neurodevelopment and thermogenesis |
| DIO3 | Type III iodothyronine deiodinase; inactivates T4 and T3 by inner-ring deiodination | Plays a role in fetal development and cancer |
| SECISBP2 | Selenocysteine insertion sequence-binding protein 2; required for selenoprotein synthesis | Mutations cause thyroid hormone abnormalities |
| SELENOP | Selenoprotein P; selenium transport protein | Affects deiodinase activity via selenium supply |
| GPX1 | Glutathione peroxidase 1; reduces hydrogen peroxide | May influence redox state for deiodinase activity |
| TXNRD1 | Thioredoxin reductase 1; provides reducing equivalents | Supports deiodinase catalysis |
| TXNRD2 | Thioredoxin reductase 2; mitochondrial reducing system | Potential role in deiodinase function |
| GSR | Glutathione reductase; maintains glutathione levels | Indirectly supports deiodinase activity |
| GCLC | Glutamate-cysteine ligase catalytic subunit; glutathione synthesis | Modulates redox environment |
| GCLM | Glutamate-cysteine ligase modifier subunit; glutathione synthesis | Modulates redox environment |
| NCOA1 | Nuclear receptor coactivator 1; enhances thyroid hormone receptor action | Downstream of T3 produced by deiodinases |
| NCOA2 | Nuclear receptor coactivator 2; enhances thyroid hormone receptor action | Downstream of T3 produced by deiodinases |
| MED1 | Mediator complex subunit 1; coactivator for thyroid hormone receptor | Downstream of T3 signaling |
| THRA | Thyroid hormone receptor alpha; mediates T3 action | Target of T3 generated by deiodinases |
| THRB | Thyroid hormone receptor beta; mediates T3 action | Target of T3 generated by deiodinases |
| TSHR | Thyroid stimulating hormone receptor; regulates thyroid hormone synthesis | Upstream regulator of T4 production |
| SLC16A2 | Monocarboxylate transporter 8; thyroid hormone transporter | Affects intracellular T4/T3 availability |
How Is thyroxine 5'-deiodinase activity Regulated?
Thyroxine 5'-deiodinase activity is regulated at multiple levels. Selenium availability influences the synthesis of selenoproteins, including deiodinases, as selenocysteine incorporation requires a specialized machinery involving SECIS elements. The redox state of the cell, particularly the levels of glutathione and thioredoxin, modulates enzyme activity by providing reducing equivalents. Hormonal signals such as thyroid-stimulating hormone (TSH) and thyroid hormones themselves can affect deiodinase expression in a tissue-specific manner. In the pineal gland, light exposure and sympathetic innervation regulate thyroxine 5'-deiodinase activity, linking it to circadian rhythms. Ontogenetic factors also control the developmental profile of the enzyme.
thyroxine 5'-deiodinase activity and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| DIO1 | Thyroid hormone imbalance; metabolic disorders | Knockout cell line (e.g., HepG2) for T3 production assays |
| DIO2 | Hypothyroidism-like conditions; impaired thermogenesis | Brown adipocyte knockout for thermogenesis studies |
| DIO3 | Brain tumors; developmental disorders | Overexpression in glioma cell lines to assess proliferation |
| SECISBP2 | Selenoprotein deficiency; thyroid dysfunction | Patient-derived fibroblasts with point mutations |
| SLC16A2 | Allan-Herndon-Dudley syndrome; thyroid hormone transport defect | Knock-in mouse model with patient mutation |
Thyroid Hormone Disorders
Alterations in thyroxine 5'-deiodinase activity can lead to abnormal levels of active thyroid hormone T3, contributing to hypothyroidism or hyperthyroidism. Postpartum thyroiditis, an autoimmune condition, is associated with changes in thyroid hormone metabolism, including deiodinase activity. Selenoprotein deficiencies, which impair deiodinase function, can cause thyroid hormone abnormalities.
Brain Tumors
Human brain tumors exhibit altered thyroxine 5-deiodinase activity compared to normal brain tissue, suggesting a role for local thyroid hormone metabolism in tumor biology. The type III deiodinase (DIO3) is often overexpressed in tumors and may promote proliferation by reducing local T3 levels.
Metabolic and Neurological Conditions
Dysregulation of deiodinase activity in brown adipose tissue and liver can affect energy expenditure and lipid metabolism, implicating it in obesity and metabolic syndrome. In the brain, altered deiodinase activity may influence mood and cognition, as thyroid hormones are critical for neuronal function.
From thyroxine 5'-deiodinase activity-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does DIO2 knockout reduce local T3 in the brain? | DIO2 knockout mouse or neuronal cell line |
| How does a point mutation in DIO1 affect catalytic efficiency? | CRISPR point-mutation knock-in in HEK293 cells |
| Can DIO3 overexpression drive tumor growth? | DIO3 overexpression in glioma cell lines |
| What is the role of SECISBP2 in deiodinase synthesis? | SECISBP2 knockout cell lines |
| Does tagged DIO1 localize to the plasma membrane? | Knock-in of FLAG-tagged DIO1 in thyroid cells |
| How does selenium availability affect deiodinase activity? | Selenium-depleted cell culture models |
How to Study the thyroxine 5'-deiodinase activity Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Radioiodinated T4 assay | Conversion of T4 to T3 | Tissue homogenate deiodinase activity |
| CRISPR knockout | Loss of gene function | DIO1 knockout in liver cells |
| CRISPR point mutation | Specific amino acid changes | Selenocysteine to cysteine mutation in DIO2 |
| RNA-seq | Gene expression levels | DIO gene expression in brain tumors |
| Western blot | Protein abundance | DIO1 protein levels in liver |
| Immunofluorescence | Subcellular localization | DIO2 in endoplasmic reticulum |
| Mass spectrometry | Selenoprotein identification | Global selenoproteome analysis |
| Luciferase reporter | Thyroid hormone receptor activity | T3-responsive gene expression |
Biochemical Deiodinase Assays
Thyroxine 5'-deiodinase activity is traditionally measured using radioiodinated T4 as substrate, followed by separation of products by chromatography. This method quantifies the conversion of T4 to T3 and is used to assess enzyme kinetics and tissue distribution.
CRISPR-Cas9 Gene Editing
CRISPR-Cas9 allows precise knockout, point mutation, or knock-in of DIO genes in cell lines and animal models. This enables researchers to dissect the specific contributions of each deiodinase to thyroid hormone metabolism and disease.
Transcriptomics and Proteomics
RNA-seq and proteomics can measure expression levels of DIO genes and related selenoproteins under different conditions. These approaches help identify regulatory networks and biomarkers associated with deiodinase activity.
Imaging and Localization Studies
Fluorescent tagging or immunohistochemistry can localize deiodinases within cells and tissues, revealing their subcellular distribution and trafficking. Such studies have shown endoplasmic reticulum and plasma membrane localization.
How CRISPR Can Be Used to Study GO:0004800 thyroxine 5'-deiodinase activity
Knockout
CRISPR knockout of DIO1, DIO2, or DIO3 in cell lines (e.g., HepG2, HEK293) abolishes specific deiodinase activity, allowing researchers to study compensatory mechanisms and the contribution of each enzyme to T3 production. Knockout models are essential for validating drug targets and understanding tissue-specific effects.
Point Mutation
Introducing point mutations in the selenocysteine codon (UGA) of DIO genes can reveal the importance of this residue for catalysis. For example, mutating selenocysteine to cysteine reduces catalytic efficiency, providing insights into the enzyme mechanism.
Knock-in
Knock-in of tagged versions of DIO genes (e.g., FLAG, GFP) enables visualization and immunoprecipitation of the enzyme, facilitating studies of localization, interaction partners, and dynamics. Knock-in of patient-specific mutations can model disease phenotypes in vitro.
Overexpression
Overexpression of DIO genes in cell lines or animal models can mimic pathological states such as tumors, where DIO3 is often upregulated. This approach helps identify downstream effects on proliferation, differentiation, and metabolism.
How EDITGENE Supports thyroxine 5'-deiodinase activity Research
Researchers studying thyroxine 5'-deiodinase activity-related genes often need to determine whether a candidate gene is causally involved in thyroid hormone metabolism, development, or disease. EDITGENE provides a comprehensive suite of CRISPR-based services to accelerate this research, from gene knockout to precise point mutations and overexpression models.
Contact EDITGENE today to design your custom CRISPR model for thyroxine 5'-deiodinase activity research.
Related Products
| Product name | Cat.No. | Species | Gene ID | |
|---|---|---|---|---|
| DIO2 Knockout HEK293 Cell Line | EDJ-KQ2747 | Human | 1734 | Details Get a Quote |
| DIO1 Knockout HEK293 Cell Line | EDJ-KQ4443 | Human | 1733 | Details Get a Quote |
| DIO3 Knockout HEK293 Cell Line | EDJ-KQ4446 | Human | 1735 | Details Get a Quote |
| DIO2 Knockout A-549 Cell Line | EDJ-KQ23633 | Human | 1734 | Details Get a Quote |
| DIO2 Knockout HeLa Cell Line | EDJ-KQ23634 | Human | 1734 | Details Get a Quote |
| DIO1 Knockout HeLa Cell Line | EDJ-KQ53091 | Human | 1733 | Details Get a Quote |
| DIO3 Knockout HeLa Cell Line | EDJ-KQ53092 | Human | 1735 | Details Get a Quote |
| DIO1 Knockout A-549 Cell Line | EDJ-KQ61558 | Human | 1733 | Details Get a Quote |
| DIO3 Knockout A-549 Cell Line | EDJ-KQ61559 | Human | 1735 | Details Get a Quote |
| DIO1 Knockout HCT 116 Cell Line | EDJ-KQ70049 | Human | 1733 | Details Get a Quote |
| DIO2 Knockout HCT 116 Cell Line | EDJ-KQ70050 | Human | 1734 | Details Get a Quote |
| DIO3 Knockout HCT 116 Cell Line | EDJ-KQ70051 | Human | 1735 | Details Get a Quote |
Displaying Records 1 To 12 Of 12 Records
Frequently Asked Questions About thyroxine 5'-deiodinase activity
What is thyroxine 5'-deiodinase activity?
Thyroxine 5'-deiodinase activity (GO:0004800) is the enzymatic conversion of L-thyroxine (T4) to the active thyroid hormone 3,3',5-triiodo-L-thyronine (T3) by outer-ring deiodination.
What genes are involved in thyroxine 5'-deiodinase activity?
The main genes are DIO1, DIO2, and DIO3, which encode type I, II, and III iodothyronine deiodinases, respectively.
Where is thyroxine 5'-deiodinase activity found in the body?
It is found in tissues such as the anterior pituitary, brown adipose tissue, liver, pineal gland, and frontal cortex.
How is thyroxine 5'-deiodinase activity regulated?
It is regulated by selenium availability, redox state, hormones like TSH, and in the pineal gland by light and sympathetic innervation.
What diseases are associated with thyroxine 5'-deiodinase activity?
Altered activity is linked to thyroid disorders, brain tumors, and postpartum thyroiditis.
What is the difference between type I and type II deiodinase?
Type I (DIO1) is mainly found in liver and kidney and contributes to plasma T3, while type II (DIO2) provides local T3 in brain and brown adipose tissue.
Can CRISPR be used to study thyroxine 5'-deiodinase activity?
Yes, CRISPR knockout, point mutation, and knock-in models allow precise manipulation of DIO genes to study their function.
What methods measure thyroxine 5'-deiodinase activity?
Radioiodinated T4 assays, mass spectrometry, and reporter assays are commonly used to measure deiodinase activity.
Why is thyroxine 5'-deiodinase activity important for brain function?
It provides local T3, which is essential for neuronal development and function; DIO2 is highly expressed in the brain.
How does selenium affect thyroxine 5'-deiodinase activity?
Selenium is required for selenocysteine incorporation into deiodinases; deficiency reduces enzyme activity.
Conclusion
Thyroxine 5'-deiodinase activity (GO:0004800) is a fundamental molecular function that controls the availability of active thyroid hormone T3 in tissues. Its regulation by selenoproteins, redox state, and tissue-specific factors underscores its importance in development, metabolism, and disease. Continued research using advanced CRISPR models and biochemical assays will further illuminate its roles and therapeutic potential.
References
- 1. Lu J et al.. 2009. Selenoproteins.. J Biol Chem 284(2):723-7 PMID: 18757362
- 2. Courtin F et al.. 1985. Subcellular localization of thyroxine 5'-deiodinase activity in bovine anterior pituitary.. Endocrinology 117(6):2527-33 PMID: 4065044
- 3. Leonard JL et al.. 1983. Thyroxine 5'-deiodinase activity in brown adipose tissue.. Endocrinology 112(3):1153-5 PMID: 6822208
- 4. Hardy JJ et al.. 1986. Characteristics of thyroxine 5'-deiodinase activity in human liver.. Am J Med Sci 292(4):193-7 PMID: 3752164
- 5. Guerrero JM et al.. 1988. Thyroxine 5'-deiodinase activity in pineal gland and frontal cortex: nighttime increase and the effect of either continuous light exposure or superior cervical ganglionectomy.. Endocrinology 122(1):236-41 PMID: 3335206
- 6. Murakami M et al.. 1989. Ontogenesis of pineal thyroxine 5'-deiodinase activity and plasma melatonin concentration in the rat.. Neuroendocrinology 50(4):476-80 PMID: 2812278
- 7. Mori K et al.. 1993. Thyroxine 5-deiodinase in human brain tumors.. J Clin Endocrinol Metab 77(5):1198-202 PMID: 8077312
- 8. Lazarus JH et al.. 2002. Postpartum thyroiditis.. Autoimmunity 35(3):169-73 PMID: 12389641
